Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).
Pike LRG, Miao E, Boe LA, Patil T, Imber BS, Myall NJ, Pollom EL, Hui C, Qu V, Langston J, Chiang V, Grant M, Goldberg SB, Palmer JD, Prasad RN, Wang TJC, Lee A, Shu CA, Chen LN, Thomas NJ, Braunstein SE, Kavanagh BD, Camidge DR, Rusthoven CG. Pike LRG, et al. Among authors: prasad rn. J Clin Oncol. 2024 Oct 20;42(30):3606-3617. doi: 10.1200/JCO.23.02668. Epub 2024 Jul 24. J Clin Oncol. 2024. PMID: 39047224
COVID-19 Booster Vaccine Equity for Patients With Cancer.
Prasad RN, Patel M, Palmer JD. Prasad RN, et al. Adv Radiat Oncol. 2022 Sep-Oct;7(5):100939. doi: 10.1016/j.adro.2022.100939. Epub 2022 Mar 9. Adv Radiat Oncol. 2022. PMID: 35280348 Free PMC article.
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain Metastases.
Lehrer EJ, Kowalchuk RO, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Fakhoury KR, Rusthoven CG, Mathieu D, Trudel C, Malouff TD, Ruiz-Garcia H, Bonney P, Hwang L, Yu C, Zada G, Patel S, Deibert CP, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Harmsen WS, Jones BM, Sharma S, Ahluwalia MS, Sheehan JP, Trifiletti DM. Lehrer EJ, et al. Among authors: prasad rn. Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):858-868. doi: 10.1016/j.ijrobp.2023.01.017. Epub 2023 Jan 21. Int J Radiat Oncol Biol Phys. 2023. PMID: 36690161
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
Lehrer EJ, Khosla AA, Ozair A, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Mathieu D, Trudel C, Deibert CP, Malouff TD, Ruiz-Garcia H, Peterson JL, Patel S, Bonney P, Hwang L, Yu C, Zada G, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Fakhoury KR, Rusthoven CG, Dickstein DR, Sheehan JP, Trifiletti DM, Ahluwalia MS. Lehrer EJ, et al. Among authors: prasad rn. J Neurooncol. 2023 Oct;165(1):63-77. doi: 10.1007/s11060-023-04413-4. Epub 2023 Oct 27. J Neurooncol. 2023. PMID: 37889444
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study.
Lehrer EJ, Gurewitz J, Bernstein K, Patel D, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Malouff TD, Ruiz-Garcia H, Patel S, Bonney PA, Hwang L, Yu C, Zada G, Mathieu D, Trudel C, Prasad RN, Palmer JD, Jones BM, Sharma S, Fakhoury KR, Rusthoven CG, Deibert CP, Picozzi P, Franzini A, Attuati L, Lee CC, Yang HC, Ahluwalia MS, Sheehan JP, Trifiletti DM. Lehrer EJ, et al. Among authors: prasad rn. Cancer. 2022 Apr 1;128(7):1429-1438. doi: 10.1002/cncr.34087. Epub 2022 Jan 25. Cancer. 2022. PMID: 35077586 Free article.
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
Lehrer EJ, Ahluwalia MS, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Fakhoury KR, Rusthoven CG, Mathieu D, Trudel C, Malouff TD, Ruiz-Garcia H, Bonney P, Hwang L, Yu C, Zada G, Patel S, Deibert CP, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Jones BM, Green S, Sheehan JP, Trifiletti DM. Lehrer EJ, et al. Among authors: prasad rn. J Neurosurg. 2022 Sep 16;138(5):1178-1187. doi: 10.3171/2022.7.JNS22752. Print 2023 May 1. J Neurosurg. 2022. PMID: 36115055
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients.
Lehrer EJ, Gurewitz J, Bernstein K, Kondziolka D, Fakhoury KR, Rusthoven CG, Niranjan A, Wei Z, Lunsford LD, Malouff TD, Ruiz-Garcia H, Peterson JL, Bonney P, Hwang L, Yu C, Zada G, Deibert CP, Prasad RN, Raval RR, Palmer JD, Patel S, Picozzi P, Franzini A, Attuati L, Mathieu D, Trudel C, Lee CC, Yang HC, Jones BM, Green S, Ahluwalia MS, Sheehan JP, Trifiletti DM. Lehrer EJ, et al. Among authors: prasad rn. Neurosurgery. 2022 Dec 1;91(6):872-882. doi: 10.1227/neu.0000000000002127. Epub 2022 Oct 18. Neurosurgery. 2022. PMID: 36255215
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases.
Perlow HK, Ho C, Matsui JK, Prasad RN, Klamer BG, Wang J, Damante M, Upadhyay R, Thomas E, Blakaj DM, Beyer S, Lonser R, Hardesty D, Raval RR, Prabhu R, Elder JB, Palmer JD. Perlow HK, et al. Among authors: prasad rn. Clin Transl Radiat Oncol. 2022 Nov 9;38:117-122. doi: 10.1016/j.ctro.2022.11.004. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36420099 Free PMC article.
145 results